Skip to Main Content

Author Details

Michael S Diamond
Washington University School of Medicine
1982
556
137
PMIDPaper TitleJournal TitlePublished Year
36265510Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.Nat Med2023
37808679Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.bioRxiv2023
37562033An Antiviral Role for TRIM14 in Ebola Virus Infection.J Infect Dis2023
37804831Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.Cell2023
37596281Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin<sup>®</sup>).NPJ Vaccines2023
38014196Structural and functional basis of VLDLR receptor usage by Eastern equine encephalitis virus.bioRxiv2023
37591996Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo.Nat Microbiol2023
37556325Entry receptor LDLRAD3 is required for Venezuelan equine encephalitis virus peripheral infection and neurotropism leading to pathogenesis in mice.Cell Rep2023
37749080Blockade of interferon signaling decreases gut barrier integrity and promotes severe West Nile virus disease.Nat Commun2023
37849402A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.J Infect Dis2023
37703353Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.Sci Transl Med2023
38039973A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.Cell Rep Med2023
37676002Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.J Virol2023
37347462Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ⿼40% of patients.J Exp Med2023
37251375Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography.Front Immunol2023
37012355Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2.Nat Microbiol2023
37011668SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.Nature2023
37205409Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.bioRxiv2023
37402814An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo.Nat Commun2023
37400446A rapid cell-free expression and screening platform for antibody discovery.Nat Commun2023
37133449Colocalization of Chikungunya Virus with Its Receptor MXRA8 during Cell Attachment, Internalization, and Membrane Fusion.J Virol2023
37196061A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.Sci Transl Med2023
36474012A molecular understanding of alphavirus entry and antibody protection.Nat Rev Microbiol2023
36779802Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.J Immunol2023
36647825Entry receptors - the gateway to alphavirus infection.J Clin Invest2023
36711984Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.bioRxiv2023
36638211prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.Proc Natl Acad Sci U S A2023
36411391A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins.Nat Chem Biol2023
34846168Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.Sci Transl Med2022
35412328Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.Sci Transl Med2022
35771946IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2.Sci Immunol2022
35679349A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice.PLoS Pathog2022
35584653mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.Med2022
35677079Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins.bioRxiv2022
35677067A Multitrait Locus Regulates Sarbecovirus Pathogenesis.bioRxiv2022
35732734Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.Nature2022
35472136An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer.J Clin Invest2022
35347138Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.Nat Commun2022
35604092The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.mBio2022
35788185Considering innate immune responses in SARS-CoV-2 infection and COVID-19.Nat Rev Immunol2022
35452622Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.Cell2022
35420472Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.mBio2022
35688161mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.Cell Rep Med2022
35523172Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.Cell Rep2022
35780162Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.Nat Commun2022
35484405Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants.Nat Biotechnol2022
36618402SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients.Front Immunol2022
36459536Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters.PLoS Pathog2022
35907675Innate antiviral immunity: how prior exposures can guide future responses.Trends Immunol2022
35867819Cryo-EM structures of alphavirus conformational intermediates in low pH-triggered prefusion states.Proc Natl Acad Sci U S A2022
  • 1 - 50 of 556

Recommended Authors

Tianyang Mao
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 2
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 9
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 19
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 17
Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 3
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 9
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 3
Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year 2012
Number of shared co-authors 13
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 14
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 8
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 5
Yiska Weisblum
Rockefeller University
Career Start Year 2011
Number of shared co-authors 4
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 10
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 11
Clayton R Morrison
University of North Carolina School of Medicine
Career Start Year 2008
Number of shared co-authors 23
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 28
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 2
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 2
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 13
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 2005
Number of shared co-authors 14
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 0
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 14
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 31
Jean K Lim
Icahn School of Medicine at Mount Sinai
Career Start Year 1998
Number of shared co-authors 14
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 21
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 28
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 21
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 6
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 18
Alan C Whitmore
University of North Carolina at Chapel Hill
Career Start Year 1973
Number of shared co-authors 28

Collaborators

Rita E Chen
Co-authored papers 67
James E Crowe
Vanderbilt University Medical Center
Co-authored papers 51
Larissa B Thackray
Washington University School of Medicine
Co-authored papers 35
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers 35
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 34
Robert H Carnahan
Vanderbilt University Medical Center
Co-authored papers 21
Mehul S Suthar
Co-authored papers 19
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 18
Matthew J Gorman
Co-authored papers 17
Pavlo Gilchuk
Vanderbilt University Medical Center
Co-authored papers 17
Adrianus C M Boon
Co-authored papers 16
William B Klimstra
Co-authored papers 15
Ralph S Baric
University of North Carolina
Co-authored papers 15
Michael G Rossmann
Purdue University
Co-authored papers 14
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 14
David Veesler
Co-authored papers 13
Michael J Holtzman
Co-authored papers 12
Alexandra C Walls
Co-authored papers 10
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Co-authored papers 9
Xuping Xie
University of Texas Medical Branch
Co-authored papers 9
Scott A Handley
Washington University School of Medicine
Co-authored papers 9
Galit Alter
Co-authored papers 9
Lauren Carter
Co-authored papers 8
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Co-authored papers 8
Maxim N Artyomov
Co-authored papers 7
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Michael L Gross
Washington University in St. Louis
Co-authored papers 7
Siyuan Ding
Washington University School of Medicine
Co-authored papers 7
David Baker
University of Washington
Co-authored papers 7
Dan H Barouch
Co-authored papers 6
Release 1.2